Brainstorm cell therapeutics announces third quarter 2023 financial results and provides corporate update

Conference call and webcast at 8:30 a.m. eastern time today new york , nov. 14, 2023 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the third quarter ended september 30, 2023 and provided a corporate update.
BCLI Ratings Summary
BCLI Quant Ranking